BofA cuts ratings on four biopharma stocks over valuation and catalyst concerns

BofA cuts ratings on four biopharma stocks over valuation and catalyst concerns

Jun 29, 2026 - 19:00
 0  1
BofA cuts ratings on four biopharma stocks over valuation and catalyst concerns
BofA cuts ratings on four biopharma stocks over valuation and catalyst concerns

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow